Answers are grounded in this paper and cite their sources.
Background Poland introduced universal adolescent human papillomavirus (HPV) vaccination only in June 2023, and coverage remains low. Because clinicians' recommendations strongly influence uptake, future physicians' preparedness matters. Polish studies report aggregate scores, which cannot show which facts are missing and so cannot guide curricular change. We mapped fourth-year medical students' baseline HPV knowledge at item level and assessed the feasibility of a multidisciplinary educational module. Methods In February 2024, within the Horizon 2020 project RIVER-EU, we conducted a cross-sectional knowledge assessment with an embedded single-arm pre–post feasibility component at the University of Zielona Góra, Poland. All 96 fourth-year students, none of whom had begun the infectious-diseases course, were invited to a voluntary five-hour expert-led webinar. A 20-item single-choice questionnaire was administered immediately before and after. The primary outcome was item difficulty; analyses comprised Wilson 95% confidence intervals, corrected item–total correlations, Kuder–Richardson Formula 20 (KR-20) with KR-20-if-item-deleted, and McNemar's exact test with Bonferroni–Holm correction. Reporting follows TREND. Results Fifty-four of 96 invited students (56.2%) provided complete paired data: 37 women, 17 men. Mean baseline score was 13.19/20 (SD 3.76); KR-20 0.79. Performance varied more than fivefold across items (18.5–98.1%), so the mean concealed the educationally relevant pattern. Four items were answered correctly by half the cohort or fewer: cervical cancer as an uncommon individual outcome of infection (18.5%), the cervical cancer burden in Ukraine (20.4%), the vaccines' registered age (35.2%) and adult schedules (50.0%). All four discriminated acceptably (corrected item–total r 0.23–0.44), so none is an artifact of item construction. Natural history and epidemiology was the weakest domain (50.0%), virology and vaccine science the strongest (77.0%); sexes did not differ (p = 0.27). All 54 subsequently scored 20/20, but this ceiling, on an immediate unproctored post-test, is uninterpretable as learning. Conclusions Deficits concentrated in the applied and epidemiological content of HPV prevention - eligibility, age indications, dose schedules and individual cancer risk after infection not in the biology of the virus or its vaccines. The module was feasible to deliver and evaluate; controlled studies with proctored, delayed assessment are needed before claiming effectiveness.
No takes yet. Share an insight, caveat, or question.
Duda-Duma et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: